Clinical trial

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Therapy

NCT07805538

Study summary

ClinicalTrials.gov

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Therapy

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention Standard Boost. Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Boost Omission Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2026-09-01

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Standard Boost.RADIATION

Boost OmissionRADIATION

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07805538 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.